Cargando…

TIGIT as a Promising Therapeutic Target in Autoimmune Diseases

Co-inhibitory receptors (IRs) are molecules that protect host against autoimmune reactions and maintain peripheral self-tolerance, playing an essential role in maintaining immune homeostasis. In view of the substantial clinical progresses of negative immune checkpoint blockade in cancer treatment, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yue, Chenran, Gao, Sheng, Li, Shuting, Xing, Zhouhang, Qian, Hengrong, Hu, Ying, Wang, Wenqian, Hua, Chunyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203892/ https://www.ncbi.nlm.nih.gov/pubmed/35720417 http://dx.doi.org/10.3389/fimmu.2022.911919

Ejemplares similares

Promising Roles of Exosomal microRNAs in Systemic Lupus Erythematosus
por: Wang, Wenqian, et al.
Publicado: (2021)

TIGIT-Fc as a Potential Therapeutic Agent for Fetomaternal Tolerance
por: Fu, Wenyan, et al.
Publicado: (2021)

TIGIT: A promising target to overcome the barrier of immunotherapy in hematological malignancies
por: Jin, Shenhe, et al.
Publicado: (2022)

T memory stem cell characteristics in autoimmune diseases and their promising therapeutic values
por: Fazeli, Pooria, et al.
Publicado: (2023)

Role of CD155/TIGIT in Digestive Cancers: Promising Cancer Target for Immunotherapy
por: Wang, Daijun, et al.
Publicado: (2022)

CD47 as a promising therapeutic target in oncology
por: Zhao, Hai, et al.
Publicado: (2022)

The role of inflammation in autoimmune disease: a therapeutic target
por: Xiang, Yu, et al.
Publicado: (2023)

Self-delivery of TIGIT-blocking scFv enhances CAR-T immunotherapy in solid tumors
por: Yang, Fan, et al.
Publicado: (2023)

CD226 and TIGIT Cooperate in the Differentiation and Maturation of Human Tfh Cells
por: Yasutomi, Motoko, et al.
Publicado: (2022)

TIGIT Blockade Exerts Synergistic Effects on Microwave Ablation Against Cancer
por: Chen, Yaping, et al.
Publicado: (2022)

Immune Checkpoints as Therapeutic Targets in Autoimmunity
por: Paluch, Christopher, et al.
Publicado: (2018)

Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
por: Huang, Jie, et al.
Publicado: (2021)

TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer
por: Ge, Zhouhong, et al.
Publicado: (2021)

Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT
por: Zeven, Katty, et al.
Publicado: (2023)

Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets?
por: Iragavarapu-Charyulu, Vijaya, et al.
Publicado: (2020)

SIRT1: A Potential Therapeutic Target in Autoimmune Diseases
por: Shen, Pan, et al.
Publicado: (2021)

Imbalance of the CD226/TIGIT Immune Checkpoint Is Involved in the Pathogenesis of Primary Biliary Cholangitis
por: Deng, Chuiwen, et al.
Publicado: (2020)

TIGIT Induces (CD3+) T Cell Dysfunction in Colorectal Cancer by Inhibiting Glucose Metabolism
por: Shao, Qi, et al.
Publicado: (2021)

Co-Expression of TIGIT and Helios Marks Immunosenescent CD8(+) T Cells During Aging
por: Pieren, Daan K. J., et al.
Publicado: (2022)

TIGIT-related transcriptome profile and its association with tumor immune microenvironment in breast cancer
por: Zhang, Qin, et al.
Publicado: (2021)

The gastrointestinal-brain-microbiota axis: a promising therapeutic target for ischemic stroke
por: Wei, Yan-hao, et al.
Publicado: (2023)

TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma
por: Raphael, Itay, et al.
Publicado: (2021)

Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancer
por: Boissière-Michot, Florence, et al.
Publicado: (2022)

The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
por: Raker, Verena Katharina, et al.
Publicado: (2016)

The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
por: Sun, Haoyu, et al.
Publicado: (2019)

Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer
por: Peng, Hui, et al.
Publicado: (2022)

Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?
por: Gianchecchi, Elena, et al.
Publicado: (2021)

Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases
por: Zhai, Yujia, et al.
Publicado: (2021)

Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target
por: You, Ruixuan, et al.
Publicado: (2022)

GARP as a Therapeutic Target for the Modulation of Regulatory T Cells in Cancer and Autoimmunity
por: Zimmer, Niklas, et al.
Publicado: (2022)

Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment
por: Zhang, Nana, et al.
Publicado: (2023)

Renin-angiotensin system: The underlying mechanisms and promising therapeutical target for depression and anxiety
por: Gong, Sizhu, et al.
Publicado: (2023)

The extracellular vesicles targeting tumor microenvironment: a promising therapeutic strategy for melanoma
por: Li, Yongmin, et al.
Publicado: (2023)

Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation
por: Han, Jin-Hwan, et al.
Publicado: (2020)

The human microbiome: A promising target for lung cancer treatment
por: Sun, Ying, et al.
Publicado: (2023)

B7 family protein glycosylation: Promising novel targets in tumor treatment
por: Xiao, Linlin, et al.
Publicado: (2022)

Targeting heat shock proteins 90 and 70: A promising remedy for both autoimmune bullous diseases and COVID-19
por: Kasperkiewicz, Michael, et al.
Publicado: (2022)

Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth in vivo by Suppressing the Function of NK and CD8(+) T Cells
por: Zhou, Xiu-Man, et al.
Publicado: (2018)

Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals
por: Yin, Xiaowan, et al.
Publicado: (2018)

A reporter gene assay for determining the biological activity of therapeutic antibodies targeting TIGIT
por: Fu, Zhihao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5abbvb5t5l3s6mrrvqp4nu94u2